Article
Adaptation-proof SARS-CoV-2 vaccine design
2022-05-18
Abstract excerpt
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) surface spike glycoprotein - a major antibody target - is critical for virus entry via engagement of human angiotensin-converting enzyme 2 (ACE2) receptor. Despite successes with existing vaccines and therapies that primarily target the receptor binding domain (RBD) of the spike protein, the susceptibility of RBD to mutations provides escape routes for t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 675f07da-3197-53cc-b653-5146a4ade8ab
- DOI
- 10.1101/2022.05.17.492310
